Diagnosing the Future: Proteins, Biosensors and Fundamental Science with Prof. Eleonora Macchia

The episode opens with Prof. Eleonora Macchia describing how her ERC‑funded project began as a pure physics question—how proteins segregate in thin films and undergo topological transitions. By probing these fundamental mechanisms, her team uncovered an amplification effect that can be harnessed for a biosensor capable of detecting disease‑related proteins at the earliest stages. This bridge from frontier research to a clinical trial underscores why investment in basic science is essential for breakthroughs such as non‑invasive pancreatic cancer screening, where a single mutated protein like CD55 can signal a precancerous lesion before imaging can detect a tumor.

Macchia then explains why conventional protein assays, such as ELISA, fall short of preventive medicine needs. Their detection limit sits in the micromolar range, requiring millions of protein copies per sample and missing low‑abundance biomarkers. The CMOT (single‑molecule with a large transistor) platform flips this paradigm: a five‑millimeter electrode packed with roughly 10¹² capture antibodies creates a massive sensing surface that overcomes diffusion barriers. When a target protein binds, the event propagates across neighboring antibodies, generating an electronic current change far above the noise floor. By shifting statistical thresholds from three‑sigma to six‑sigma, the system dramatically reduces false‑negative and false‑positive rates, delivering true single‑molecule sensitivity essential for early‑stage oncology and infectious‑disease diagnostics.

Finally, the conversation highlights the interdisciplinary path that made these advances possible. Macchia’s journey—from a physics bachelor to a chemistry PhD, then bioelectronics and chemometrics—exemplifies the merging of physics, chemistry, medicine, and data science. As an ERC ambassador, she advocates for policies that fund such cross‑disciplinary research, arguing that tomorrow’s point‑of‑care devices will move from doctor’s offices into homes, transforming reactive sick care into proactive health monitoring. The episode thus paints a vivid picture of how fundamental protein science, advanced transistor engineering, and AI‑driven analytics converge to reshape preventive diagnostics.